The combination of 5-fluorouracil, leukovorin, etoposide, and cisplatin (FLEP) in patients with metastatic esophageal cancer. A single-institution experience

Anticancer Research

Volumn 28, Issue 6 B, 2008, Pages 4101-4104

  Jonak, Constanze ^a   Raderer, Markus ^a   Zacherl, Johannes ^a   Prager, Gerhard ^a   Troch, Marlene ^a   Ba Ssalamah, Ahmed ^a   Hejna, Michael ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Prince Court Medical Centre ^*  (Malaysia)

Author keywords

Chemotherapy; Cisplatin; Esophageal cancer; Etoposide; FLEP; Fluorouracil; Leukovorin

Indexed keywords

CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; ESOPHAGUS CANCER; FEMALE; HUMAN; INFECTION; LEUKOPENIA; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; ESOPHAGEAL NEOPLASMS; ETOPOSIDE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RETROSPECTIVE STUDIES;

EID: 58149148384     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Daly JM, Karnell LH and Menck HR: National Cancer Data Base report on esophageal carcinoma. Cancer 78: 1820-1828, 1996.
2. Grünberger B, Raderer M, Schmidinger M and Hejna M: Palliative chemotherapy for recurrent and metastatic esophageal cancer. Anticancer Res 27: 2705-2714, 2007.
3. Hejna M: State of the art and future perspectives in cytostatic treatment of esophageal cancer. Europ Surg 39: 151-157, 2007.
4. Polee MB, Kok TC, Siersema PD, Tilanus HW, Splinter TA, Stoter G and Van der Gaast A: Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus. Anticancer Drugs 12: 513-517, 2001.
5. Stahl M, Wilke H, Meyer HJ, Preusser P, Berns T, Fink U, Achterrath W, Knipp H, Harstrick A, Berger M and Schmoll HJ: 5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus. Eur J Cancer 30: 325-328, 1994.
6. Hecht JR, Blanke CD, Benson AB 3rd and Lenz HJ: Irinotecan and paclitaxel in metastatic adenocarcinoma of the esophagus and gastric cardia. Oncology (Williston Park) 17: 13-15, 2003.
7. Ilson DH and Minsky B: Irinotecan in esophageal cancer. Oncology (Williston Park) 17: 32-36, 2003.
8. Evans D, Miner T, Iannitti D, Akerman P, Cruff D, Maia-Acuna C, Harrington D, Habr F, Chauhan B, Berkenblit A, Stuart K, Sears D, Kennedy T and Safran H: Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study. Cancer Invest 25: 445-448, 2007.
9. Tew WP, Kelsen DP and Ilson DH: Targeted therapies for esophageal cancer. Oncologist 10: 590-601, 2005.